The DOI matches its Crossref record; 558 of the 563 references it cites were found in a registry or an index.
The lipid paradox in neuroprogressive disorders: Causes and consequences
Open accessAbstract
Chronic systemic inflammation is associated with an increased risk of cardiovascular disease in an environment of low low-density lipoprotein (LDL) and low total cholesterol and with the pathophysiology of neuroprogressive disorders. The causes and consequences of this lipid paradox are explored. Circulating activated neutrophils can release inflammatory molecules such as myeloperoxidase and the pro-inflammatory cytokines interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha. Since activated neutrophils are associated with atherosclerosis and cardiovascular disease and with major depressive disorder, bipolar disorder and schizophrenia, it seems reasonable to hypothesise that the inflammatory molecules released by them may act as mediators of the link between systemic inflammation and the development of atherosclerosis in neuroprogressive disorders. This hypothesis is tested by considering the association at a molecular level of systemic inflammation with increased LDL oxidation; increased small dense LDL levels; increased lipoprotein (a) concentration; secretory phospholipase A 2 activation; cytosolic phospholipase A 2 activation; increased platelet activation; decreased apolipoprotein A1 levels and function; decreased paroxonase-1 activity; hyperhomocysteinaemia; and metabolic endotoxaemia. These molecular mechanisms suggest potential therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over the last two decades, chronic systemic inflammation and immunity are relevant to the pathophysiology of SCZ3 and BD.4”
From Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder (2023) · cites this paper as [3]
Citations
Cites
2 retracted
Items 201–400 of 558
Kebir, D. E., József, L., Khreiss, T., Pan, W., Petasis, N. A., Serhan, C. N., & Filep, J. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.616 · Cited by 139
MAPK- Kinases as Nucleo-Cytoplasmic Shuttles for PPARγ
Burgermeister, E., & Seger, R. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4453 · Cited by 138
Catapano, A. L., Pirillo, A., & Norata, G. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13805 · Cited by 138
The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease
Czapski, G. A., Czubowicz, K., Strosznajder, J. B., & Strosznajder, R. P. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1776-x · Cited by 137
Start a fire, kill the bug: The role of platelets in inflammation and infection
Deppermann, C., & Kubes, P. (2018) · Innate Immunity · doi:10.1177/1753425918789255 · Cited by 136
Ghose, R., Zimmerman, T. L., Thevananther, S., & Karpen, S. J. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-4 · Cited by 135
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Morris, G., Walker, A. J., Berk, M., Maes, M. H. J., & Puri, B. K. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0793-y · Cited by 134
Self-citationHuang, J. T.-J., Wang, L., Prabakaran, S., Wengenroth, M., Lockstone, H. E., Koethe, D., Gerth, C. W., Gross, S., Schreiber, D., Lilley, K. S., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002108 · Cited by 133
Carneiro, A. B., Iaciura, B. M. F., Nohara, L. L., Lopes, C. D., Cordero, E. M., Mariano, V. S., Bozza, P. T., Lopes, U. G., Atella, G. C., de Almeida, I. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076233 · Cited by 133
Hoen, W. P., Lijmer, J. G., Durán, M., Wanders, R. J. A., van Beveren, N. J. M., & de Haan, L. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.041 · Cited by 132
Opposite Regulation of the Human Paraoxonase-1 Gene PON-1 by Fenofibrate and Statins
Gouédard, C., Koum-Besson, N., Barouki, R., & Morel, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.945 · Cited by 132
Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines
Murugesan, G. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.08.004 · Cited by 131
Pleiotropic effects of oxidized phospholipids
Bochkov, V. N., Gesslbauer, B., Mauerhofer, C., Philippova, M., Erné, P., & Oskolkova, O. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.034 · Cited by 129
Enas, E. A., Varkey, B., Dharmarajan, T. S., Paré, G., & Bahl, V. K. (2019) · Indian Heart Journal · doi:10.1016/j.ihj.2019.03.004 · Cited by 128
Xu, J., Weng, Y., Simonyi, Á., Krugh, B. W., Liao, Z., Weisman, G. A., & Sun, G. Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01145.x · Cited by 127
Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment
Yao, Y., Clark, C. M., Trojanowski, J. Q., Lee, V. M. ‐., & Praticò, D. (2005) · Annals of Neurology · doi:10.1002/ana.20558 · Cited by 126
Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells
Dransfield, I., Zagórska, A., Lew, E. D., Michail, K., & Lemke, G. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.18 · Cited by 125
Flood, C., Gustafsson, M. V., Pitas, R. E., Arnaboldi, L., Walzem, R. L., & Borén, J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000117174.19078.85 · Cited by 125
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
Orsó, E., & Schmitz, G. (2017) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-017-0084-1 · Cited by 125
Prieto, P., Cuenca, J., Través, P. G., Fernández‐Velasco, M., Martín‐Sanz, P., & Boscá, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.220 · Cited by 123
Yadav, D. K., Kumar, S., Choi, E. H., Chaudhary, S., & Kim, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40913-y · Cited by 123
Mastorikou, M., Mackness, B., Liu, Y., & Mackness, M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02546.x · Cited by 122
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients
Kim, H., Рапопорт, С. И., & Rao, J. S. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.137 · Cited by 122
Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity
Allen, S. P., Khan, S., Tam, S., Koschinsky, M. L., Taylor, P., & Yacoub, M. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1765 · Cited by 121
Wysokiński, A., Strzelecki, D., & Kłoszewska, I. (2015) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.004 · Cited by 120
The role of lipid biomarkers in major depression
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S. (2017) · Healthcare · doi:10.3390/healthcare5010005 · Cited by 120
van der Kemp, W. J. M., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Pol, H. E. H. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.014 · Cited by 119
Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S -nitrosylation
Ruiz, F. A., Corrales, F. J., Miqueo, C., & Mato, J. M. P. (1998) · Hepatology · doi:10.1002/hep.510280420 · Cited by 118
Sartipy, P., Camejo, G., Svensson, L., & Hurt‐Camejo, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25913 · Cited by 118
Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest
Dixit, N., & Simon, S. I. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00188 · Cited by 117
LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism
Carnevale, R., Bartimoccia, S., Nocella, C., Santo, S. D., Loffredo, L., Illuminati, G., Lombardi, E., Boz, V., Ben, M. D., Marco, L. D., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.041 · Cited by 116
Gut Microbiome and Cardiovascular Diseases
Yoshida, N., Yamashita, T., & Hirata, K. (2018) · Diseases · doi:10.3390/diseases6030056 · Cited by 116
Moludi, J., Maleki, V., Vayghan, H. J., Vaghef‐Mehrabany, E., & Alizadeh, M. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13250 · Cited by 115
Fraley, A. E., Schwartz, G. G., OLSSON, A. G., Kinlay, S., Szarek, M. J., Rifai, N., Libby, P., Ganz, P., Witztum, J. L., & Tsimikas, S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.041 · Cited by 113
Yang, E. H., McConnell, J. P., Lennon, R. J., Barsness, G. W., Pumper, G. M., Hartman, S. J., Rihal, C. S., Lerman, L. O., & Lerman, A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191655.87296.ab · Cited by 113
Experimental human endotoxemia as a model of systemic inflammation
van Lier, D. P. T., Geven, C., Leijte, G. P., & Pickkers, P. (2018) · Biochimie · doi:10.1016/j.biochi.2018.06.014 · Cited by 112
Hakala, J. K., Öörni, K., Pentikäinen, M. O., Hurt‐Camejo, E., & Kovanen, P. T. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.1053 · Cited by 111
Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure
Pignatelli, P., Biase, L. D., Lenti, L., Tocci, G., Brunelli, A., Cangemi, R., Riondino, S., Grego, S., Volpe, M., & Violi, F. (2005) · Blood · doi:10.1182/blood-2005-03-1247 · Cited by 110
Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
Delporte, C., Antwerpen, P. V., Vanhamme, L., Roumeguère, T., & Boudjeltia, K. Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/971579 · Cited by 109
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque
Shea, S., Stein, J. H., Jorgensen, N. W., McClelland, R. L., Tascau, L., Shrager, S., Heinecke, J. W., Yvan‐Charvet, L., & Tall, A. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311366 · Cited by 109
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
Morris, G., Bortolasci, C. C., Puri, B. K., OLIVE, L. S., Marx, W., O'Neil, A. E., Athan, E., Carvalho, A. F., Maes, M. H. J., Walder, K. R., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118166 · Cited by 107
Self-citationTertov, V. V., Sobenin, I. A., Ахнафович, Г. З., Popov, E. G., Jaakkola, O., Solakivi, T., Nikkari, T., Smirnov, V. N., & Orekhov, A. N. (1992) · PubMed · Cited by 107
Ebtehaj, S., Gruppen, E. G., Bakker, S. J. L., Dullaart, R. P. F., & Tietge, U. J. F. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312645 · Cited by 105
Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104
Gurda, D., Handschuh, L., Kotkowiak, W., & Jakubowski, H. (2015) · Amino Acids · doi:10.1007/s00726-015-1956-7 · Cited by 104
Wooton‐Kee, C. R., Boyanovsky, B. B., Nasser, M. S., de Villiers, W. J. S., & Webb, N. R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000122363.02961.c1 · Cited by 103
Li, X., Wang, L., Fang, P., Sun, Y., Jiang, X., Wang, H., & Yang, X. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002752 · Cited by 103
Magkos, F., Mohammed, B. S., & Mittendorfer, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.164 · Cited by 102
Jakubowski, H., Boers, G. H. J., & Strauss, K. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-112086 · Cited by 100
Orekhov, A. N., Bobryshev, Y. V., Sobenin, I. A., Melnichenko, A. А., & Chistiakov, D. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712807 · Cited by 100
Carracedo, M., Artiach, G., Arnardottir, H. H., & Bäck, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00767-y · Cited by 100
Sun, G. Y., Chuang, D. Y., Zong, Y., Jiang, J., Lee, J. C., Gu, Z., & Simonyi, Á. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8662-4 · Cited by 99
The molecular basis of homocysteine thiolactone-mediated vascular disease
Jakubowski, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.338 · Cited by 99
Systemic lupus erythematosus and “lupus dyslipoproteinemia”
de Carvalho, J. F., Bonfá, E., & Borba, E. F. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.11.016 · Cited by 99
Lim, K., Han, C. L., Xu, L., Isse, K., Demetris, A. J., & Wu, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2295 · Cited by 97
Trans‐4‐hydroxy‐2‐hexenal is a neurotoxic product of docosahexaenoic (22:6; n‐3) acid oxidation
Long, E. K., Murphy, T. C., Leiphon, L. J., Watt, J. A., Morrow, J. D., Milne, G. L., Howard, J. R. H., & Picklo, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05175.x · Cited by 97
Kunutsor, S. K., Bakker, S. J. L., James, R. W., & Dullaart, R. P. F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.021 · Cited by 97
Price, N. L., Rotllán, N., Zhang, X., Canfrán‐Duque, A., Nottoli, T., Suárez, Y., & Fernandez-Hernando, C. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.314415 · Cited by 97
DiDonato, J. A., Aulak, K. S., Huang, Y. R., Wagner, M. A., Gerstenecker, G. S., Topbas, C., Gogonea, V., DiDonato, A. J., Tang, W. H. W., Mehl, R. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556506 · Cited by 96
Sachais, B. S., Kuo, A., Nassar, T., Morgan, J. M., Karikó, K., Williams, K. J., Feldman, M. D., Aviram, M., Shah, N., Jarett, L., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3613 · Cited by 96
Majdalawieh, A. F., & Ro, H.-S. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08004 · Cited by 94
Excess Mortality in Bipolar Disorders
Miller, C. J., & Bauer, M. S. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0499-z · Cited by 94
Meital, L. T., Windsor, M., Perissiou, M., Schulze, K., Magee, R., Kuballa, A., Golledge, J., Bailey, T. G., Askew, C. D., & Russell, F. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-49362-z · Cited by 94
Decreased paraoxonase activity in critically ill patients with sepsis
Novak, F. J., Vávřová, L., Kodydková, J., Novak, F. J., Hynkova, M., Žák, A., & Novakova, O. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0059-8 · Cited by 94
Maes, M. H. J., Sirivichayakul, S., Kanchanatawan, B., & Vojdani, A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00054-6 · Cited by 93
Self-citationAtherosclerosis and systemic lupus erythematosus — mechanistic basis of the association
McMahon, M. A., & Hahn, B. H. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.11.001 · Cited by 92
Secretory Phospholipase A2Group V
Rosengren, B. E., Peilot, H., Umaerus, M., Jönsson‐Rylander, A., Hultén, L. M., Hallberg, C., Cronet, P., Rodrı́guez-Lee, M., & Hurt‐Camejo, E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000221231.56617.67 · Cited by 92
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Borovčanin, M., Jovanović, I., Radosavljevic, G. D., Pantic, J. M., Janicijevic, S. M., Arsenijević, N., & Lukić, M. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00221 · Cited by 92
Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
Brennan, E. P., Mohan, M., McClelland, A., de Gaetano, M., Tikellis, C., Marai, M., Crean, D., Dai, A., Beuscart, O., Derouiche, S., et al. (2018) · Diabetes · doi:10.2337/db17-1317 · Cited by 92
Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins
Zambon, A., Bertocco, S., Vitturi, N., Polentarutti, V., Vianello, D., & Crepaldi, G. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311070 · Cited by 91
Cotticelli, M. G., Crabbe, A. M., Wilson, R. B., & Shchepinov, M. S. (2013) · Redox Biology · doi:10.1016/j.redox.2013.06.004 · Cited by 91
Phospholipase A2 and small, dense low-density lipoprotein
Hurt‐Camejo, E., Camejo, G., & Sartipy, P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00004 · Cited by 90
Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.
Boonmark, N. W., Lou, X. J., Yang, Z. J., Schwartz, K., Zhang, J. L., Rubin, E. M., & Lawn, R. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119565 · Cited by 90
Qiu, H., Johansson, A., Sjöström, M., Wan, M., Schröder, O., Palmblad, J. E. W., & Haeggström, J. Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602208103 · Cited by 89
Inflammation and peripheral arterial disease: The value of circulating biomarkers (Review)
Signorelli, S. S., Fiore, V., & Malaponte, G. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1657 · Cited by 88
Lipoprotein(a) in Cardiovascular Diseases
Malaguarnera, M., Vacante, M., Russo, C., Malaguarnera, G., Antic, T., Malaguarnera, L., Bella, R., Pennisi, G., Galvano, F., & Frigiola, A. (2012) · BioMed Research International · doi:10.1155/2013/650989 · Cited by 88
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Hsu, M., Huang, Y. S., & Ouyang, W. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01337-0 · Cited by 88
The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients
Dietrich‐Muszalska, A., Malinowska, J., Olas, B., Głowacki, R., Bald, E., Wachowicz, B., & Rabe‐Jabłońska, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0707-3 · Cited by 88
Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity
Pirro, M., Bianconi, V., Paciullo, F., Mannarino, M. R., Bagaglia, F., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.001 · Cited by 87
Kim, K. P., Rafter, J. D., Bittova, L., Han, S. K., Snitko, Y., Muñoz, N. M., Leff, A. R., & Cho, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004604200 · Cited by 87
Neutrophils in cardiovascular disease
Gaul, D. S., Stein, S. M. A., & Matter, C. M. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx244 · Cited by 87
The regulation of inflammation by oxidized phospholipids
Freigang, S. (2016) · European Journal of Immunology · doi:10.1002/eji.201545676 · Cited by 86
Oxidized phospholipids in control of inflammation and endothelial barrier
Fu, P., & Birukov, K. G. (2009) · Translational Research · doi:10.1016/j.trsl.2008.12.005 · Cited by 86
Mental Disorders Across the Adult Life Course and Future Coronary Heart Disease
Galé, C. R., Batty, G. D., Osborn, D., Tynelius, P., & Rasmussen, F. E. (2013) · Circulation · doi:10.1161/circulationaha.113.002065 · Cited by 85
Yarla, N. S., Bishayee, A., Vadlakonda, L., Chintala, R., Duddukuri, G. R., Reddanna, P., & Kaladhar, D. S. V. G. K. (2016) · Current Drug Targets · doi:10.2174/1389450116666150727122501 · Cited by 85
Karabina, S., Brochériou, I., Naour, G. L., Agrapart, M., Durand, H., Gelb, M. H., Lambeau, G. J., & Ninio, E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6018fje · Cited by 85
Shao, B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.11.011 · Cited by 84
Oxidative stress in blood platelets from schizophrenic patients
Dietrich‐Muszalska, A., Olas, B., & Rabe‐Jabłońska, J. (2005) · Platelets · doi:10.1080/09537100500128872 · Cited by 84
Duah, E., Adapala, R. K., Al‐Azzam, N. Z., Kondeti, V., Gombedza, F., Thodeti, C. K., & Paruchuri, S. M. (2013) · Scientific Reports · doi:10.1038/srep03274 · Cited by 84
Endotoxemia-induced inflammation and the effect on the human brain
van den Boogaard, M., Ramakers, B. P., van Alfen, N., van der Werf, S. P., Fick, W. F., Hoedemaekers, C. W., Verbeek, M. M., Schoonhoven, L., van der Hoeven, J. G., & Pickkers, P. (2010) · Critical Care · doi:10.1186/cc9001 · Cited by 84
Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
Li, C., Wu, X., Liu, S., Shen, D., Zhu, J., & Liu, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00612 · Cited by 83
Bortolasci, C. C., Vargas, H. O., Souza-Nogueira, A., Barbosa, D. S., Moreira, E. G., Nunes, S. O. V., Berk, M., Dodd, S., & Maes, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.018 · Cited by 83
Self-citationHaraguchi, Y., Toh, R., Hasokawa, M., Nakajima, H., Honjo, T., Otsui, K., Mori, K., Miyamoto–Sasaki, M., Shinohara, M., Nishimura, K., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.009 · Cited by 82
Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
Solberg, D. K., Bentsen, H., Refsum, H., & Andreassen, O. A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1006-3 · Cited by 82
Kakeda, S., Watanabe, K., Katsuki, A., Sugimoto, K., Igata, N., Ueda, I., Igata, R., Abe, O., Yoshimura, R., & Korogi, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-28300-5 · Cited by 82
Kumon, Y., Suehiro, T., Ikeda, Y., & Hashimoto, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00704-5 · Cited by 82
Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions
Karabina, S.-A. P., Liapikos, T. A., Grekas, G., Goudevenos, J. A., & Tselepis, A. D. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90219-4 · Cited by 82
High-Density Lipoproteins and the Immune System
Kaji, H. (2013) · Journal of Lipids · doi:10.1155/2013/684903 · Cited by 81
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease
Fu, T., Mohan, M., Brennan, E. P., Woodman, O. L., Godson, C., Kantharidis, P., Ritchie, R. H., & Qin, C. X. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00097 · Cited by 81
Thul, S., Labat, C., Temmar, M., Benetos, A., & Bäck, M. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317694464 · Cited by 81
Lipoprotein(a): Cellular Effects and Molecular Mechanisms
Riches‐Suman, K., & Porter, K. E. (2012) · Cholesterol · doi:10.1155/2012/923289 · Cited by 80
Platelets as Central Mediators of Systemic Inflammatory Responses
Smith, T., & Weyrich, A. S. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.10.013 · Cited by 79
Boyanovsky, B. B., van der Westhuyzen, D. R., & Webb, N. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502067200 · Cited by 79
Review: The role of paraoxonase in cardiovascular diseases.
Kowalska, K., Socha, E., & Milnerowicz, H. (2015) · PubMed · Cited by 79
Yang, B., Fritsche, K. L., Beversdorf, D. Q., Gu, Z., Lee, J. C., Folk, W. R., Greenlief, C. M., & Sun, G. Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00642 · Cited by 78
Zhang, Y., Wang, Y., Zhou, D. F., Zhang, L.-S., Deng, F., Shu, S., Wang, L., Wu, Y., Guo, N., Zhou, J., et al. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00145.2019 · Cited by 77
Lipid Paradox in Acute Myocardial Infarction—The Association With 30-Day In-Hospital Mortality
Cheng, K., Chu, C., Lin, T., Lee, K., Sheu, S., & Lai, W. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000946 · Cited by 77
Maeda, S., Nakanishi, S., Yoneda, M., Awaya, T., Yamane, K., Hirano, T., & Kohno, N. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11445 · Cited by 76
Morris, G., Anderson, G., Gałecki, P., Berk, M., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-64 · Cited by 76
Self-citationLoffredo, S., Borriello, F., Iannone, R., Ferrara, A. L., Galdiero, M. R., Gigantino, V., Esposito, P. B., Varricchi, G., Lambeau, G. J., Cassatella, M. A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00443 · Cited by 75
Maes, M. H. J., Kanchanatawan, B., Sirivichayakul, S., & Carvalho, A. F. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9987-y · Cited by 75
Self-citationMomin, M., Jia, J., Fan, F., Li, J., Dou, J., Chen, D., Huo, Y., & Zhang, Y. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0441-6 · Cited by 75
Özyurt, G., & Binici, N. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.007 · Cited by 74
Proatherogenic effects of 4-hydroxynonenal
Nègre‐Salvayre, A., Garoby-Salom, S., Swiader, A., Rouahi, M., Pucelle, M., & Salvayre, R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.038 · Cited by 74
Fan, J., Liu, Y., Yin, S., Chen, N., Bai, X., Ke, Q., Shen, J., & Xia, M. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0334-y · Cited by 74
Palavra, F., Marado, D., Mascarenhas‐Melo, F., Sereno, J., Teixeira‐Lemos, E., Nunes, C. C., Gonçalves, G., Teixeira, F. J., & Reis, F. (2013) · Disease Markers · doi:10.1155/2013/567162 · Cited by 74
The role of phospholipases A2 in schizophrenia
Law, M. H., Cotton, R. G. H., & Berger, G. E. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001819 · Cited by 73
Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins
Panzenboeck, U., & Stocker, R. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.003 · Cited by 73
Chang, M., Lee, J., Chen, Y., Lin, S.-I., Lin, L., Liou, E. J., Huang, W., Chan, C., Huang, C.-C., & Jeng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22425 · Cited by 73
Chen, L., Dai, H., Dai, Z., Chong-tao, X., & Wu, R. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12138 · Cited by 72
Lehto, S. M., Niskanen, L., Tolmunen, T., Hintikka, J., Viinamäki, H., Heiskanen, T., Honkalampi, K., Kokkonen, M., & Koivumaa‐Honkanen, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02079.x · Cited by 72
Macphee, C. H., NELSON, J., & Zalewski, A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.008 · Cited by 71
Expression of secretory phospholipase A2s in human atherosclerosis development
Kimura-Matsumoto, M., Ishikawa, Y., Komiyama, K., Tsuruta, T., Murakami, M., Masuda, S., Akasaka, Y., Ito, K., Ishiguro, S., Morita, H., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.062 · Cited by 71
Pellegrino, M. W., Furmaniak-Kazmierczak, E., LeBlanc, J. C., Cho, T., Cao, K., Marcovina, S. M., Boffa, M. B., Côté, G. P., & Koschinsky, M. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309705200 · Cited by 71
Morris, G., Walder, K. R., Puri, B. K., Berk, M., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9392-y · Cited by 70
Self-citationSimvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
Barale, C., Frascaroli, C., Senkeev, R., Cavalot, F. L., & Russo, I. (2018) · BioMed Research International · doi:10.1155/2018/6508709 · Cited by 70
Granata, F., Frattini, A., Loffredo, S., Prete, A. D., Sozzani, S., Marone, G., & Triggiani, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200535567 · Cited by 70
Morin, C. L., Schlaepfer, I. R., & Eckel, R. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117844 · Cited by 70
High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters
Yüksel, R. N., Ertek, İ. E., Dikmen, A. U., & Göka, E. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1458899 · Cited by 70
Inanli, I., Aydin, M., Çaliskan, A. M., & Eren, I. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1640789 · Cited by 69
Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC
Birukova, A. A., Starosta, V., Tian, X., Higginbotham, K., Koroniak, Ł., Berliner, J. A., & Birukov, K. G. (2013) · Translational research · doi:10.1016/j.trsl.2012.12.008 · Cited by 69
Lluís, L., Taltavull, N., Muñoz-Cortés, M., Sánchez‐Martos, V., Romeu, M., Giralt, M., Molinar‐Toribio, E., Torres, J. L., Pérez‐Jiménez, J., Pazos, M., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-140 · Cited by 68
Tellis, C. C., & Tselepis, A. D. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140622200916 · Cited by 68
Al-Khalaifah, H. S. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.569939 · Cited by 68
Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
Czechowska, G., Celiński, K., Korolczuk, A., Wójcicka, G., Dudka, J., Bojarska, A., & Reiter, R. J. (2015) · PubMed · Cited by 68
Pichler, G., Amigó, N., Téllez-Plaza, M., Pardo-Cea, M. Á., Dominguez-Lucas, A., Marrachelli, V. G., Monleón, D., Martı́n-Escudero, J. C., Ascaso, J. F., Chaves, F. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.128 · Cited by 67
Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis
Labat, C., Temmar, M., Nagy, E., Bean, K., Brink, C., Bénétos, A., & Bäck, M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328363dccc · Cited by 67
Lai, L., Azzam, K. M., Lin, W.-C., Rai, P., Lowe, J. M., Gabor, K. A., Madenspacher, J. H., Aloor, J. J., Parks, J. S., Näär, A. M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.723056 · Cited by 67
Mean platelet volume in bipolar disorder:The search for an ideal biomarker
Mert, D. G., & Terzi, H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s112374 · Cited by 67
Min, J., Jain, M. K., Wilder, C., Paul, L. S., Apitz-Castro, R. J., Aspleaf, D., & Gelb, M. H. (1999) · Biochemistry · doi:10.1021/bi991149u · Cited by 66
Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes
Younis, N. N., Soran, H., Pemberton, P. W., Charlton-Menys, V., Elseweidy, M. M., & Durrington, P. N. (2012) · Clinical Science · doi:10.1042/cs20120304 · Cited by 66
Olofsson, P. S., Sheikine, Y., Jatta, K., Ghaderi, M., Samnegård, A., Eriksson, P. O., & Sirsjö, A. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1150 · Cited by 66
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
Ooi, E. M. M., Chan, D. T., Watts, G. F., Chan, D. C., Ng, T. W., Dogra, G. K., Irish, A. B., & Barrett, P. H. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011163 · Cited by 66
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress
Anwar, A., Keating, A. K., Joung, D., Sather, S., Kim, G. K., Sawczyn, K. K., Brandão, L., Henson, P. M., & Graham, D. K. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608334 · Cited by 65
Franceschini, G., Cassinotti, M., Vecchio, G., Gianfranceschi, G., Pazzucconi, F., Murakami, T., Sirtori, M., D'Acquarica, A. L., & Sirtori, C. R. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1569 · Cited by 64
Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation
Oehler, B., Kistner, K., Martin, C., Schiller, J., Mayer, R., Mohammadi, M., Sauer, R., Filipović, M. R., Nieto, F. R., Kloka, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05348-3 · Cited by 64
Kim, E. A., Kim, J. A., Park, M. H., Jung, S., Suh, S. H., Pang, M., & Kim, Y. J. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802556075 · Cited by 64
Lung mast cells are a source of secreted phospholipases A2
Triggiani, M., Giannattasio, G., Calabrese, C., Loffredo, S., Granata, F., Fiorelli, A., Santini, M., Gelb, M. H., & Marone, G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.035 · Cited by 63
Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
Smith, J. D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.007 · Cited by 62
Guirgis, F. W., Dodani, S., Leeuwenburgh, C., Moldawer, L. L., Bowman, J., Kalynych, C. J., Grijalva, V. R., Reddy, S. T., Jones, A. E., & Moore, F. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203813 · Cited by 62
Myeloperoxidase induces the priming of platelets
Kolarova, H., Klinke, A., Kremserová, S., Adam, M., Pekarová, M., Baldus, S. E., Eiserich, J. P., & Kubala, L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.014 · Cited by 62
Lind, L., & Lithell, H. (1994) · PubMed · Cited by 62
Lipoquality control by phospholipase A2 enzymes
Murakami, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.043 · Cited by 61
Hummel, J., Westphal, S., Weber-Hamann, B., Gilles, M., Lederbogen, F., Angermeier, T., Luley, C., Deuschle, M., & Kopf, D. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05853blu · Cited by 60
Sobenin, I. A., Salonen, J. T., Викторович, Ж. А., Melnichenko, A. А., Kaikkonen, J., Bobryshev, Y. V., & Orekhov, A. N. (2014) · BioMed Research International · doi:10.1155/2014/205697 · Cited by 60
Folate and Inflammation – links between folate and features of inflammatory conditions
Jones, P. R., Lucock, M. D., Scarlett, C. J., Veysey, M. J., & Beckett, E. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2019.100104 · Cited by 60
Moreira, E. G., Correia, D. G., Bonifácio, K. L., Moraes, J. B., Cavicchioli, F. L., Nunes, C. S., Nunes, S. O. V., Vargas, H. O., Barbosa, D. S., & Maes, M. H. J. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1322219 · Cited by 59
Self-citationPON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients
Kotur‐Stevuljević, J., Spasić, S., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., Stefanović, A., Vujović, A., Memon, L., & Kalimanovska‐Oštrić, D. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.06.009 · Cited by 59
Lipid abnormalities in patients with Rheumatoid Arthritis
Erum, U., Ahsan, T., & Khowaja, D. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.331.11699 · Cited by 59
Starosta, V., Wu, T., Zimman, A., Pham, D., Tian, X., Oskolkova, O., Bochkov, V. N., Berliner, J. A., Birukova, A. A., & Birukov, K. G. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0153oc · Cited by 58
Ohmura, H., Mokuno, H., Sawano, M., Hatsumi, C., Mitsugi, Y., Watanabe, Y., Daida, H., & Yamaguchi, H. (2002) · Metabolism · doi:10.1053/meta.2002.34695 · Cited by 58
Vuilleumier, N., Bratt, J., Alizadeh, R., Jogestrand, T., Hafström, I., & Frostegård, J. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009741003742755 · Cited by 58
Grimm, M. O. W., Haupenthal, V. J., Mett, J., Stahlmann, C. P., Blümel, T., Mylonas, N. T., Endres, K., Grimm, H. S., & Hartmann, T. (2015) · Neurodegenerative Diseases · doi:10.1159/000440839 · Cited by 58
Hurtado-Roca, Y., Bueno, H., Fernández‐Ortíz, A., Ordovás, J. M., Ibáñez, B., Fuster, V., Rodríguez‐Artalejo, F., & Laclaustra, M. (2016) · Diabetes · doi:10.2337/db16-0933 · Cited by 58
Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis
Wu, B. C., Walker, J., Spur, B. W., Rodríguez, A. R., & Yin, K. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.11.005 · Cited by 56
Sato, H., Isogai, Y., Masuda, S., Taketomi, Y., Miki, Y., Kamei, D., Hara, S., Kobayashi, T., Ishikawa, Y., Ishii, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206755 · Cited by 56
LDL are oxidatively modified by platelets via GP91 phox and accumulate in human monocytes
Carnevale, R., Pignatelli, P., Lend, L., Buchetti, B., Sanguigni, V., Santo, S. D., & Violi, F. (2006) · The FASEB Journal · doi:10.1096/fj.06-6908com · Cited by 56
Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., & Maes, M. H. J. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160914182822 · Cited by 56
Self-citationProtein homocysteinylation: a new mechanism of atherogenesis?
Bełtowski, J. (2005) · PubMed · Cited by 56
Biomarkers of One-Carbon Metabolism Are Associated with Biomarkers of Inflammation in Women
Abbenhardt, C., Miller, J. W., Song, X., Brown, E. C., Cheng, T. D., Wener, M. H., Zheng, Y., Toriola, A. T., Neuhouser, M. L., Beresford, S. A. A., et al. (2014) · Journal of Nutrition · doi:10.3945/jn.113.183970 · Cited by 56
Prasad, A., Clopton, P., Ayers, C. R., Khera, A., de Lemos, J. A., Witztum, J. L., & Tsimikas, S. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309101 · Cited by 55
Herbert, S. P., Odell, A. F., Ponnambalam, S., & Walker, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701541200 · Cited by 55
Moe, K. T., Khairunnisa, K., Yin, N. O., Chin-Dusting, J. P. F., Wong, P. E. H., & Wong, M. C. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0345-0 · Cited by 54
Chana, R. S., Lewington, A. J. P., & Brunskill, N. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00624.x · Cited by 54
Tertov, V. V., Bittolo-Bon, G., Sobenin, I. A., Cazzolato, G., Orekhov, A. N., & Avogaro, P. (1995) · Experimental and Molecular Pathology · doi:10.1006/exmp.1995.1018 · Cited by 54
Koga, N., Ogura, J., Yoshida, F., Hattori, K., Hori, H., Aizawa, E., Ishida, I., & Kunugi, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0536-0 · Cited by 54
Wysokiński, A., & Szczepocka, E. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.034 · Cited by 54
Bouaziz, N., Ayedi, I., Sidhom, O., Kallel, A., Rafrafi, R., Jomaa, R., Melki, W., Feki, M., Kaabechi, N., & Hechmi, Z. E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.008 · Cited by 53
Zhou, M., Wu, R., Dong, W., Jacob, A., & Wang, P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00340.2007 · Cited by 53
Nou, E., Lu, M. T., Looby, S. E. D., Fitch, K. V., Kim, E. A., Lee, H., Hoffmann, U., Grinspoon, S. K., & Lo, J. (2015) · AIDS · doi:10.1097/qad.0000000000000946 · Cited by 53
Majdalawieh, A. F., & Ro, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.003 · Cited by 52
Alexandros, D. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160009 · Cited by 52
Song, Y., Wu, B. C., Yang, Y., Chen, J., Zhang, L. J., Zhang, Z. W., Shi, H., Huang, C., Pan, J., & Xie, P. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154550 · Cited by 51
Ammirati, E., Bozzolo, E. P., Contri, R., Baragetti, A., Palini, A. G., Cianflone, D., Banfi, M., Uboldi, P., Bottoni, G., Scotti, I., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.006 · Cited by 51
Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis
Salagre, E., Vizuete, A. F. K., Leite, M. C., Brownstein, D. J., McGuinness, A. J., Jacka, F. N., Dodd, S., Stubbs, B., Köhler, C. A., Vieta, E., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.02.482 · Cited by 51
Self-citationMiksa, M., Wu, R., Cui, X., Dong, W., Das, P., Simms, H. H., Ravikumar, T. S., & Wang, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6263 · Cited by 51
Boudjeltia, K. Z., Legssyer, I., Antwerpen, P. V., Lema-Kisoka, R., Babar, S., Moguilevsky, N., Delrée, P., Ducobu, J., Remacle, C., Vanhaeverbeek, M., et al. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-061 · Cited by 50
Neutrophils in atherosclerosis
Roig, C., Daemen, M. J. A. P., Lutgens, E., Soehnlein, O., & Hartwig, H. (2014) · Hämostaseologie · doi:10.5482/hamo-14-09-0040 · Cited by 50
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL
Boyanovsky, B. B., Shridas, P., Simons, M., van der Westhuyzen, D. R., & Webb, N. R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800450-jlr200 · Cited by 50
The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
Lucas, K., Morris, G., Anderson, G., & Maes, M. H. J. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150317224645 · Cited by 50
Self-citationThe Gut Microbiome in Bipolar Disorder and Pharmacotherapy Management
Flowers, S. A., Ward, K. M., & Clark, C. T. (2019) · Neuropsychobiology · doi:10.1159/000504496 · Cited by 50
Wu, G., Brouckaert, P., & Olivecrona, T. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2003 · Cited by 50
Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis
Viigimaa, M., Abina, J., Zemtsovskaja, G., Tikhaze, A. K., Георгиевна, К. Г., Kumskova, E. M., & Lankin, V. Z. (2010) · Blood Pressure · doi:10.3109/08037051.2010.484158 · Cited by 49
Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction
Zimetti, F., VUONO, S. D., Gomaraschi, M., Adorni, M. P., Favari, E., Ronda, N., Ricci, M. A., Veglia, F., Calabresi, L., & Lupattelli, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p076463 · Cited by 49
Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
Boiko, A. S., Mednova, I. A., Kornetova, E. G., Semke, A. V., Bokhan, N. A., LOONEN, A. J. M., & Ivanova, S. А. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02033 · Cited by 49
Simeonova, D., Stoyanov, D., Leunis, J., Carvalho, A. F., Kubera, M., Murdjeva, M., & Maes, M. H. J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00126-7 · Cited by 49
Self-citationDiNicolantonio, J. J., & O’Keefe, J. H. (2019) · Open Heart · doi:10.1136/openhrt-2019-001011 · Cited by 48
Endothelial cell regulation by phospholipid oxidation products
Berliner, J. A., & Gharavi, N. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.013 · Cited by 48
Giles, J. T., Wasko, M. C., Chung, C. P., Szklo, M., Blumenthal, R. S., Kao, A. H., Bokhari, S., Zartoshti, A., Stein, C. M., & Bathon, J. M. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40889 · Cited by 48
Flagged first, then by citations
5 of the 563 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Döring, 2015, Neutrophils in atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 35, 288, 10.1161/ATVBAHA.114.303564 · DOI
- Huang, 2013, Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex, J. Clin. Invest., 123, 3815, 10.1172/JCI67478 · DOI · Paper page
Cited by
Sorted by citations
Balestra, C., Lambrechts, K., Mrakic‐Sposta, S., Vezzoli, A., Lévénez, M., Germonpré, P., Virgili, F., Bosco, G., & Lafère, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179600 · Cited by 41
Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect
Hong, D.-Y., Lee, D.-H., Lee, J., Lee, E.-C., Park, S.-W., Lee, M. R., & Oh, J. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158384 · Cited by 38
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
Giorgi, R. D., Pesci, N. R., Rosso, G., Maina, G., Cowen, P. J., & Harmer, C. J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02533-z · Cited by 31
Karpouzas, G. A., Ormseth, S. R., Ronda, N., Hernández, E., & Budoff, M. J. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102815 · Cited by 22
Shared postulations between bipolar disorder and polycystic ovary syndrome pathologies
Dai, W., Liu, J., Qiu, Y., Teng, Z., Li, S., Huang, J., Xiang, H., Tang, H., Wang, B., Chen, J., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110498 · Cited by 15
Metadata
- Authors
- Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K.
- Affiliations
- Barwon Health (AU)
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 128
- Pages
- 35-57
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W3170312532
- Cited by
- 17
- References
- 563
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 2
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion)
- PubMed (publishedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Health and Medical Research Council (1059660)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- lipid paradox, neurodegenerative diseases, platelet activation, apolipoprotein A-I, hyperhomocysteinemia, endotoxemia, lipid metabolism, therapeutic target
- MeSH terms
- Humans, Inflammation, Lipids, Lipoproteins, LDL, Peroxidase, Neutrophils, Cytokines, Neurodegenerative Diseases, Atherosclerosis, Phospholipases A2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review